REVEAL: Reduction of Infarct Expansion and Ventricular Remodeling With Erythropoietin After Large Myocardial Infarction

• Status: Completed
• Trial end date: 2011-01-01

Summary

The purpose of this study is to evaluate whether erythropoietin can help limit the damage to the heart in patients with acute heart attacks.

• Phase: Phase 2

Details

• Lead Sponsor: National Institute on Aging (NIA)
• Treatments: Epoetin Alfa